Effects of triheptanoin (UX007) in patients with long‐chain fatty acid oxidation disorders: Results from an open‐label, long‐term extension study

Long‐chain fatty acid oxidation disorders (LC‐FAOD) are autosomal recessive conditions that impair conversion of long‐chain fatty acids into energy, leading to significant clinical symptoms. Triheptanoin is a highly purified, 7‐carbon chain triglyceride approved in the United States as a source of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Vockley, Jerry, Burton, Barbara, Berry, Gerard, Longo, Nicola, Phillips, John, Sanchez‐Valle, Amarilis, Chapman, Kimberly, Tanpaiboon, Pranoot, Grunewald, Stephanie, Murphy, Elaine, Lu, Xiaoxiao, Cataldo, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891391/
https://www.ncbi.nlm.nih.gov/pubmed/32885845
http://dx.doi.org/10.1002/jimd.12313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891391/
https://www.ncbi.nlm.nih.gov/pubmed/32885845
http://dx.doi.org/10.1002/jimd.12313

Ejemplares similares